20062019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

Repeatability of [ 18 F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients

Kolinger, G. D., Vállez García, D., Kramer, G. M., Frings, V., Smit, E. F., de Langen, A. J., Dierckx, R. A. J. O., Hoekstra, O. S. & Boellaard, R., 2019, In : EJNMMI Research. 9, 14.

Research output: Contribution to journalArticleAcademicpeer-review

Treatment of oncogene-driven non-small cell lung cancer

Kastelijn, E. A., de Langen, A. J. & Peters, B. J. M., 2019, In : Current opinion in pulmonary medicine. 25, 3, p. 300-307

Research output: Contribution to journalArticleAcademicpeer-review

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLC

van Veggel, B., de Langen, A. J., Hashemi, S. M. S., Monkhorst, K., Heideman, D. A. M., Thunnissen, E. & Smit, E. F., 1 Aug 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1222-1226 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses

van Veggel, B., de Langen, A. J., Hashemi, S., Monkhorst, K., Rosenberg, E. H., Heideman, D. A. M., Radonic, T. & Smit, E. F., 2018, In : Lung Cancer. 124, p. 130-134 5 p.

Research output: Contribution to journalArticleAcademicpeer-review